Royal College of Surgeons in Ireland
Browse
Sudden sensorineural hearing loss following immunization .....pdf (500.91 kB)

Sudden sensorineural hearing loss following immunization with BNT162b2 or mRNA-1273: a Danish population-based cohort study

Download (500.91 kB)
journal contribution
posted on 2023-07-19, 15:46 authored by Per Damkier, Brian ClearyBrian Cleary, Jesper Hallas, Jesper H Schmidt, Louise Ladebo, Peter B Jensen, Lars Christian Lund

Objective: To compare the occurrence of sudden sensorineural hearing loss following immunization with BNT162b2 (Comirnaty®; Pfizer BioNTech) or mRNA-1273 (Spikevax®; Moderna) to the occurrence among unvaccinated individuals.

Study design: Cohort study.

Setting: Nationwide Danish health care registers comprised all Danish residents living in Denmark on October 1, 2020, who were 18 years or older or turned 18 in 2021.

Methods: We compared the occurrence of sudden sensorineural hearing loss following immunization with BNT162b2 (Comirnaty®; Pfizer BioNTech) or mRNA-1273 (Spikevax®; Moderna) (first, second, or third dose) against unvaccinated person time. Secondary outcomes were a first-ever hospital diagnosis of vestibular neuritis and a hearing examination, by an ear-nose-throat (ENT) specialist, followed by a prescription of moderate to high-dose prednisolone.

Results: BNT162b2 or mRNA-1273 vaccine was not associated with an increased risk of receiving a discharge diagnosis of sudden sensorineural hearing loss (adjusted hazard ratio [HR]: 0.99, confidence interval [CI]: 0.59-1.64) or vestibular neuritis (adjusted HR: 0.94, CI: 0.69-1.24). We found a slightly increased risk (adjusted HR: 1.40, CI, 1.08-1.81) of initiating moderate to high-dose oral prednisolone following a visit to an ENT specialist within 21 days from receiving a messenger RNA (mRNA)-based Covid-19 vaccine.

Conclusion: Our findings do not suggest an increased risk of sudden sensorineural hearing loss or vestibular neuritis following mRNA-based COVID-19 vaccination. mRNA-Covid-19 vaccination may be associated with a small excess risk of a visit to an ENT specialist visit followed by a prescription of moderate to high doses of prednisolone.

History

Comments

The original article is available at https://aao-hnsfjournals.onlinelibrary.wiley.com/

Published Citation

Damkier P. et al. Sudden sensorineural hearing loss following immunization with BNT162b2 or mRNA-1273: a Danish population-based cohort study. Otolaryngol Head Neck Surg. 2023 Dec;169(6):1472-1480.

Publication Date

8 June 2023

PubMed ID

37288514

Department/Unit

  • School of Pharmacy and Biomolecular Sciences

Publisher

Wiley

Version

  • Published Version (Version of Record)